在神经退行性疾病中的Staufen2失调
Sharan Paul1, Warunee Dansithong1, Karla P Figueroa1
1Department of Neurology, University of Utah, Salt Lake City, Utah, USA.
The Journal of biological chemistry
|February 15, 2025
概括
在SCA2和ALS等神经退行性疾病中,Staufen2 (STAU2) 蛋白升高. 恢复微RNAmiR-217水平可以降低STAU2和mTOR,从而提供治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- Staufen2 (STAU2) 是一种参与mRNA调节的RNA结合蛋白.
- 在神经退行性疾病模型中,STAU1是STAU2的类型,在神经退行性疾病模型中升高.
- 在神经退行症中STAU2的作用尚不清楚.
研究的目的:
- 在神经退行性疾病模型中研究STAU2蛋白水平.
- 探索STAU2,mTOR信号传递和microRNAmiR-217.7之间的功能关系.
主要方法:
- 在患者衍生细胞和动物模型中量化STAU2蛋白和mRNA.
- 涉及外源STAU2表达和RNA干扰 (RNAi) 的细胞试验.
- 分析miR-217针对STAU2的定位及其对mTOR信号传递的影响.
主要成果:
- 在各种神经退行性疾病模型 (SCA2,ALS,FTD) 中,STAU2蛋白,但不是mRNA,显著升高.
- 过度表达STAU2诱导mTOR激活和压力颗粒形成.
- 针对STAU2的RNAi在疾病模型中使mTOR水平正常化.
- miR-217直接针对STAU2,其恢复降低了STAU2和mTOR水平.
结论:
- STAU2蛋白失调与神经退行性疾病有关.
- 在STAU2和mTOR信号通路之间存在一个功能链接.
- miR-217代表了涉及STAU2和mTOR失调的疾病的潜在治疗标.
相关概念视频
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
01:26Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
03:14Notch Signaling Pathway
4.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
02:17Microtubule Instability
4.9K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
4.9K
01:22Alzheimer's Disease: Treatment
150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150